Orthofix Medical Inc. last reported quarterly results on Aug 5, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $210.9 million (+3.8% year over year) and diluted EPS of -$0.39. It usually reports 9–55 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 3, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Nov 4, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 9–55 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
211
+3.8%
|
-16
-12.2%
|
-0.39
-8.3%
|
|
Apr 9, 2026
9 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
197
+1.6%
|
-21
+60.6%
|
-0.52
+61.5%
|
|
Feb 24, 2026
55 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
220
+2.0%
|
-2
+92.4%
|
-0.06
+92.6%
|
|
Nov 4, 2025
35 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
206
+4.6%
|
-23
+16.8%
|
-0.57
+19.7%
|
|
Aug 5, 2025
36 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
203
+2.3%
|
-14
+57.9%
|
-0.36
+59.1%
|
|
May 6, 2025
36 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
194
+2.7%
|
-53
-47.4%
|
-1.35
-42.1%
|
|
Feb 25, 2025
56 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
216
+7.6%
|
-29
-31.4%
|
-0.75
-26.1%
|
|
Nov 7, 2024
38 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
197
+6.8%
|
-27
+5.1%
|
-0.71
+7.8%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OFIX (Nasdaq)
- Fiscal year ends
- December 23
- Headquarters
- Lewisville, TX
- SEC filer status
- Accelerated filer
- SEC CIK
- 884624
- Former names
- ORTHOFIX INTERNATIONAL N V (until Aug 1, 2018)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.